The Lead Episode 177: A Discussion of the PIFPAF-PFA Randomized Clinical Trial-The Lead Episode 177 Video

Video Transcription

Video Summary

The podcast reviews the Swiss PIFP-PAF randomized trial, comparing pulsed-field ablation (PFA) with pulmonary vein isolation (PVI) alone versus PVI plus posterior wall isolation in 206 patients with symptomatic persistent atrial fibrillation. All patients received implantable monitors and were followed for one year.<br /><br />The primary outcome—atrial tachyarrhythmia lasting over 30 seconds between months 3 and 12—occurred in roughly 60% of the PVI-only group and 50% of the combined-treatment group. This difference was not statistically significant. However, posterior wall isolation reduced longer AF episodes and average AF burden, suggesting possible clinical benefit. Safety outcomes were reassuring.<br /><br />Discussants emphasized that the trial may have been underpowered and questioned whether brief, monitor-detected episodes are a meaningful measure of success. They viewed the findings as encouraging but not definitive: posterior wall isolation may help selected patients, though its incremental benefit and the best candidates for treatment remain uncertain.

Keywords

persistent atrial fibrillation

pulsed-field ablation

pulmonary vein isolation

posterior wall isolation

randomized trial